Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:approves |
gptkb:2007
|
| gptkbp:available_in |
various strengths
|
| gptkbp:available_on |
gptkb:tablet
|
| gptkbp:brand |
gptkb:Zyrtec
Zyrtec Allergy & Congestion |
| gptkbp:class |
gptkb:Antihero
decongestant |
| gptkbp:clinical_trial |
Zyrtec-D efficacy study
Zyrtec-D safety study |
| gptkbp:contains |
gptkb:pseudoephedrine
cetirizine |
| gptkbp:contraindication |
gptkb:Ophthalmology
severe hypertension urinary retention severe coronary artery disease |
| gptkbp:dosage_form |
gptkb:liquid
chewable tablet 1 tablet daily |
| gptkbp:formulation |
extended release
immediate release |
| https://www.w3.org/2000/01/rdf-schema#label |
Zyrtec-D
|
| gptkbp:ingredients |
cetirizine hydrochloride
pseudoephedrine sulfate |
| gptkbp:interacts_with |
gptkb:beer
MAO inhibitors other antihistamines |
| gptkbp:is_recommended_for |
nasal congestion
hay fever seasonal allergies sinus pressure |
| gptkbp:manufacturer |
gptkb:Johnson_&_Johnson
|
| gptkbp:packaging |
blister pack
|
| gptkbp:patient_population |
consult healthcare provider
|
| gptkbp:release_region |
gptkb:Australia
gptkb:Canada gptkb:Mexico gptkb:United_Kingdom gptkb:United_States |
| gptkbp:requires |
over-the-counter
|
| gptkbp:shelf_life |
check packaging for date
|
| gptkbp:side_effect |
dizziness
nausea confusion drowsiness dry mouth skin rash rapid heartbeat severe allergic reaction swelling of face or throat |
| gptkbp:storage |
store at room temperature
|
| gptkbp:suitable_for |
pregnant women
children under 12 nursing mothers |
| gptkbp:used_for |
allergy relief
|
| gptkbp:bfsParent |
gptkb:Vicks
|
| gptkbp:bfsLayer |
5
|